Literature DB >> 17090190

Evaluation of C4d staining in liver and small intestine allografts.

Megan L Troxell1, John P Higgins, Neeraja Kambham.   

Abstract

CONTEXT: Antibody-mediated humoral rejection in kidney and heart allografts is well recognized and is often associated with poor outcome. C4d deposition in allograft biopsy specimens occurs at sites of antibody-mediated complement activation and has become one of the histopathologic criteria for diagnosis of humoral rejection in the kidney and the heart.
OBJECTIVE: To study immunohistochemical C4d staining as a potential diagnostic marker in liver and small intestine allograft biopsy specimens.
DESIGN: Thirty-six small intestine and 71 liver specimens, including native specimens, allografts with and without histologic features of acute cellular rejection, and explants, were stained with antisera to C4d using an immunohistochemical method on formalin-fixed, paraffin-embedded tissue.
RESULTS: In small intestine, C4d labeled capillaries in 27% of cases with no evidence of rejection, 36% of cases with evidence of acute rejection, and 2 (28%) of 7 specimens of native normal small intestine. In liver allograft biopsy specimens, C4d stained endothelium of veins, arteries, and/or sinusoids in 2 (8%) of 25 cases of acute rejection with central vein involvement; C4d staining was negative in biopsy specimens with no evidence of rejection. C4d stained the endothelium in a subset of explanted liver allografts with ductopenic rejection or chronic vascular rejection and strongly stained 1 explant with features of hyperacute rejection.
CONCLUSIONS: The clinical utility of C4d staining in solid organ transplantation may vary by organ. Our data show C4d is unlikely to have utility in small intestine allograft biopsy specimens; however, further study in liver allografts, in conjunction with donor-specific antibody testing, is warranted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17090190     DOI: 10.5858/2006-130-1489-EOCSIL

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  13 in total

1.  Dimensions of antibody-mediated rejection.

Authors:  R B Colvin
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

2.  Prevalence and Clinical Impact of Donor-Specific Alloantibody Among Intestinal Transplant Recipients.

Authors:  Elaine Y Cheng; Matthew J Everly; Hugo Kaneku; Nubia Banuelos; Laura J Wozniak; Robert S Venick; Elizabeth A Marcus; Suzanne V McDiarmid; Ronald W Busuttil; Paul I Terasaki; Douglas G Farmer
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

3.  The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.

Authors:  A I Musat; R M Agni; P Y Wai; J D Pirsch; D F Lorentzen; A Powell; G E Leverson; J M Bellingham; L A Fernandez; D P Foley; J D Mezrich; A M D'Alessandro; M R Lucey
Journal:  Am J Transplant       Date:  2011-03       Impact factor: 8.086

Review 4.  ABO-compatible liver allograft antibody-mediated rejection: an update.

Authors:  Anthony J Demetris; Adriana Zeevi; Jacqueline G O'Leary
Journal:  Curr Opin Organ Transplant       Date:  2015-06       Impact factor: 2.640

5.  Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants.

Authors:  Sandy Feng; John C Bucuvalas; Anthony J Demetris; Bryna E Burrell; Katherine M Spain; Sai Kanaparthi; John C Magee; David Ikle; Andrew Lesniak; Juan J Lozano; Estella M Alonso; Robert A Bray; Nancy E Bridges; Edward Doo; Howard M Gebel; Nitika A Gupta; Ryan W Himes; Annette M Jackson; Steven J Lobritto; George V Mazariegos; Vicky L Ng; Elizabeth B Rand; Averell H Sherker; Shikha Sundaram; Yumirle P Turmelle; Alberto Sanchez-Fueyo
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

Review 6.  Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.

Authors:  Antonio Cuadrado; David San Segundo; Marcos López-Hoyos; Javier Crespo; Emilio Fábrega
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

7.  Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Methods Mol Biol       Date:  2013

8.  Melatonin protects liver from intestine ischemia reperfusion injury in rats.

Authors:  Jian-Yi Li; Hong-Zhuan Yin; Xi Gu; Yong Zhou; Wen-Hai Zhang; Yi-Min Qin
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

9.  Successful living donor intestinal transplantation in cross-match positive recipients: Initial experience.

Authors:  Raquel Garcia-Roca; Ivo G Tzvetanov; Hoonbae Jeon; Elisabeth Hetterman; Jose Oberholzer; Enrico Benedetti
Journal:  World J Gastrointest Surg       Date:  2016-01-27

Review 10.  Updates on antibody-mediated rejection in intestinal transplantation.

Authors:  Guo-Sheng Wu
Journal:  World J Transplant       Date:  2016-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.